Sunitinib v. PD-L1 with Bevacizumab

Sunitinib v. PD-L1 with Bevacizumab

GiantsOfCancerCare

4 years
1,118 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Nicholas J. Vogelzang, MD of the University of Illinois discusses a new trial Sunitinib v. PD-L1 with Bevacizumab
Up Next Autoplay
Reducing opioids in breast cancer surgery using Bupivacaine
Reducing opioids in breast cancer surgery using Bupivacaine
Category: Acute Lymphoblastic Leukemia
678 Views
GiantsOfCancerCare 4 years
Management of Hot Flashes using SSRI, Gabapentin, Venlafaxine in patients with breast cancer
Management of Hot Flashes using SSRI, Gabapentin, Venlafaxine in patients with breast cancer
Category: Acute Lymphoblastic Leukemia
908 Views
GiantsOfCancerCare 4 years
Olanzapine Decreases Nausea and Vomiting in Patients With Esophageal, Head and Neck Cancer
Olanzapine Decreases Nausea and Vomiting in Patients With Esophageal, Head and Neck Cancer
Category: Acute Lymphoblastic Leukemia
534 Views
GiantsOfCancerCare 4 years
Scrambler therapy for the treatment of chemotherapy- induced peripheral neuropathy
Scrambler therapy for the treatment of chemotherapy- induced peripheral neuropathy
Category: Acute Lymphoblastic Leukemia
379 Views
GiantsOfCancerCare 4 years
I-SPY 2 and MK-2206 Shows Benefit For Breast Cancer Patients
I-SPY 2 and MK-2206 Shows Benefit For Breast Cancer Patients
Category: Acute Lymphoblastic Leukemia
504 Views
GiantsOfCancerCare 4 years
Checkpoint Inhibitors in Triple Negative Breast Cancer
Checkpoint Inhibitors in Triple Negative Breast Cancer
Category: Acute Lymphoblastic Leukemia
404 Views
GiantsOfCancerCare 4 years
CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer
CDK 4/6 Inhibitor Improves PFS for Patients with HR+/HER- Breast Cancer
Category: Acute Lymphoblastic Leukemia
498 Views
GiantsOfCancerCare 4 years
Scalp cooling system prevented significant hair loss in 70.3% of patients with breast cancer receiving adjuvant CTX
Scalp cooling system prevented significant hair loss in 70.3% of patients with breast cancer receiving adjuvant CTX
Category: Acute Lymphoblastic Leukemia
305 Views
GiantsOfCancerCare 4 years
Phase II Androgen Deprivation Therapy with Palbociclib
Phase II Androgen Deprivation Therapy with Palbociclib
Category: Acute Lymphoblastic Leukemia
750 Views
GiantsOfCancerCare 4 years
ETS Gene Fusions as a Predictive Biomarker in Prostate Cancer
ETS Gene Fusions as a Predictive Biomarker in Prostate Cancer
Category: Acute Lymphoblastic Leukemia
771 Views
GiantsOfCancerCare 4 years